GOVERNING JURISDICTION This Legal Notice shall be governed by and construed in accordance with English law
However, the authors emphasized that the included studies had insufficient methodological quality and relatively small sample sizes, highlighting the need for larger, rigorously designed trials to confirm these findings (82)
$219.99 Product Specifications Peptide Name: KLOW: BPC-157 + Thymosin Beta-4 + GHK-Cu + KPV Molecular Formula: C62H98N16O22 + C212H350N56O78S + C28H48CuN12O8 + C16H26N4O5 Molecular Weight: 1419.54 g/mol + 4963.44 g/mol + 744.3 g/mol + 358.39 g/mol Amino Acid Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser, Gly-His-Lys, Lys-Pro-Val Form: Lyophilized powder Quantity: BPC-157: 10 mg Thymosin Beta-4: 10 mg GHK-Cu: 50 mg KPV: 10 mg Total: 80 mg per vial Purity: 99% (HPLC, per component) Appearance: Blue lyophilized solid Packaging: Sterile vial, sealed for research handling Storage & Handling Storage recommendations are provided as general laboratory guidelines and may vary based on peptide composition and handling conditions
Animals receiving the combination therapy showed significantly lower morphological and histopathological scores, indicating better preservation of cartilage structure
Extended biological activity
.jpg)
